McKesson Appoints Brian Tyler as President and Chief Operating Officer

July 31, 2018

SAN FRANCISCO—July 31, 2018—McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating officer, McKesson Corporation, effective August 2, 2018. Tyler will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee.

“Brian is ideally suited to lead McKesson’s global operations based on his deep industry knowledge, outstanding track record as a business leader, and his commitment to operational excellence and customer success,” said Hammergren. “His broad experience as the president of multiple McKesson businesses provides him with the ideal background and perspective to help lead McKesson’s strategic initiative and drive long-term growth.”

Previously Chairman of the Management Board, McKesson Europe, Tyler has also served as president of McKesson North American Pharmaceutical Distribution and Services, McKesson U.S. Pharmaceutical, McKesson Medical-Surgical and McKesson Specialty Health, as well as executive vice president of corporate strategy and business development. His direct reports will include:

  • President, McKesson U.S. Pharmaceutical and Specialty Health
  • President, McKesson Medical-Surgical
  • CEO, McKesson Canada
  • President, McKesson Prescription Technology Solutions (MRxTS)
  • President, Transformation Initiatives
  • Chairman, Management Board, McKesson Europe

“McKesson has outstanding products, services and solutions, and world class talent,” said Tyler. "With these assets, the company is uniquely positioned to drive innovation across the healthcare supply chain that will improve value for our business partners and enable better, more cost-effective patient care. I look forward to working with our customers, manufacturing partners and McKesson’s more than 78,000 associates to deliver on that potential and accelerate McKesson’s growth.”

Tyler earned his Ph.D. and M.A. from the University of Chicago, Department of Economics in 1994, where he studied under a grant from the National Science Foundation, and earned his B.A. in economics with high honors from University of California Santa Cruz in 1989.

McKesson also announced today that Nick Loporcaro, president of McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has decided to leave McKesson to pursue other opportunities. Upon Loporcaro’ s departure on August 10, Tyler will lead this segment directly until Loporcaro’s replacement has been named.

“Nick is a talented executive and we know he will accomplish great things in his next chapter,” said Hammergren. “He has led McKesson Canada, McKesson Specialty Health and most recently, the combined U.S. Pharmaceutical and Specialty Health business. We thank him for his many contributions to McKesson and wish him the greatest success.”

About McKesson Corporation

McKesson Corporation, currently ranked 6th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit

Public Relations Contact